Enrich Layer logo svg
Nephron Pharmaceuticals logo

Nephron Pharmaceuticals

Last updated: . For recent data, use our API.

Overview

Nephron Pharmaceuticals is headquartered in West Columbia, in the Midlands region of South Carolina. The FDA approved the company's first generic respiratory medication in 1997.

Nephron Pharmaceuticals manufactures more than one billion sterile doses each year for patients, providers and partners around the world.

At our integrated South Carolina campus, we manufacture generic respiratory products and operate a 503B Outsourcing Facility. We also support pharmaceutical companies from development through commercial supply.

Our blow-fill-seal and aseptic platforms handle sterile solutions, suspensions and emulsions. On-site teams support formulation, analytical methods, clinical batches, stability programs, technology transfer and high-volume production.

Our campus spans more than 840,000 square feet. We support batch sizes up to 9,000 liters.

We welcome product orders, 503B inquiries, contract manufacturing projects, licensing opportunities and international distribution partnerships.

Learn more at nephronpharm.com.

The company's inhalation solutions and suspensions are used by patients with respiratory conditions such as asthma, emphysema and COPD. The 503B Outsourcing Facility produces sterile, pre-filled medications intended to address drug shortages in the United States. Automated systems handle manufacturing, packaging and distribution to minimize contamination. The company offers facility tours to customers and business partners. The company also supports the Kennedy Pharmacy Innovation Center at the University of South Carolina College of Pharmacy.

Funding rounds

Disclosed funding: $775M across 3 rounds. Latest: DEBT, 1 Jan 2025.

DateTypeAmount
1 Jan 2025DEBT$350M
More funding rounds via API
Get company data via API

Get company records through the Enrich Layer API. These pages show previews only.

Office locations

Latest videos from Nephron Pharmaceuticals on YouTube

  • BFS to SHIP
  • Nephron Nitrile Overview May 2025
  • Happy Fourth of July! #nitrilegloves #fireworks
  • happy national HAND roll day #handrollsushi # #nitrilegloves
View channel

Recent posts from the Nephron Pharmaceuticals blog

  • Nephron Pharmaceuticals Announces Leadership Transition

    Lou Kennedy departs from CEO role; Haywood Miller appointed Interim CEO Company remains focused on executing its transformation strategy and growth priorities while continuing to deliver safe, effective medications to customers and the patients they serve WEST COLUMBIA, S.C. – October 16, 2026 – Nephron LLC and its subsidiaries (“Nephron” or the “Company”) today announced... The post Nephron Pharmaceuticals Announces Leadership Transition appeared first on Nephron.

  • In sterile pharmaceutical manufacturing, the environment is not something you check once and move on from.

    Before, during, and after production, our cleanroom environments are actively monitored — air sampled, results documented, data trended across shifts and over time. That continuous picture of the environment is what informs lot release and what lets us stand behind every dose that leaves this facility.

Nephron Pharmaceuticals FAQ

As of 2026-10-19, Nephron Pharmaceuticals has 727 employees, based on the Enrich Layer count of person profiles that list Nephron Pharmaceuticals as their current employer. Its listed company size band is 501 to 1,000.
As of 2026-10-19, Nephron Pharmaceuticals is headquartered in West Columbia, South Carolina, US.
Nephron Pharmaceuticals was founded in 1937.
As of 2026-10-19, Nephron Pharmaceuticals is classified in the Pharmaceutical Manufacturing industry.
Nephron Pharmaceuticals manufactures more than one billion sterile doses each year for patients, providers and partners around the world. At our integrated South Carolina campus, we manufacture generic respiratory products and operate a 503B Outsourcing Facility. We also support pharmaceutical companies from development through commercial supply. Our blow-fill-seal and aseptic platforms handle sterile solutions, suspensions and emulsions. On-site teams support formulation, analytical methods, clinical batches, stability programs, technology transfer and high-volume production. Our campus spans more than 840,000 square feet. We support batch sizes up to 9,000 liters. We welcome product orders, 503B inquiries, contract manufacturing projects, licensing opportunities and international distribution partnerships. Learn more at nephronpharm.com.
As of 2026-10-19, Nephron Pharmaceuticals's official website is http://www.nephronpharm.com/.
As of 2026-10-19, Nephron Pharmaceuticals is a privately held company.